Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke

Thrombosis Research

Volumn 124, Issue 2, 2009, Pages 213-218

  Tsai, Nai Wen ^a,b   Chang, Wen Neng ^a   Shaw, Chen Fu ^b   Jan, Chung Ren ^c   Chang, Hsueh Wen ^b   Huang, Chi Ren ^a   Chen, Shang Der ^a   Chuang, Yao Chung ^a   Lee, Lian Hui ^a   Wang, Hung Chen ^a   Lee, Tsong Hai ^a   Lu, Cheng Hsien ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Flow cytometry; Ischemic stroke; Leukocyte platelet interaction; Platelet activation

Indexed keywords

ACETYLSALICYLIC ACID; CD40 LIGAND; CD63 ANTIGEN; PADGEM PROTEIN;

ACUTE DISEASE; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN INFARCTION; CELL INTERACTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CONVALESCENCE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE; LYMPHOCYTE; MALE; MONOCYTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROKE PATIENT; THROMBOCYTE; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD45; BIOLOGICAL MARKERS; BLOOD PLATELETS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; P-SELECTIN; PHYCOERYTHRIN; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; PLATELET MEMBRANE GLYCOPROTEINS; STROKE;

EID: 67349113996     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.01.012     Document Type: Article

References (34)

1. Suwanwela N., and Koroshetz W.J. Acute ischemic stroke: overview of recent therapeutic developments. Annu Rev Med 58 (2007) 89-106
2. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 (1993) 35-41
3. Lammie G.A., Brannan F., Slattery J., and Warlow C. Nonhypertensive cerebral small-vessel disease. An autopsy study. Stroke 28 (1997) 2222-2229
4. Rothwell P.M. Atherothrombosis and ischaemic stroke. BMJ 334 (2007) 379-380
5. Moulin T., Tatu L., Vuillier F., Berger E., Chavot D., and Rumbach L. Role of a stroke data bank in evaluating cerebral infarction subtypes: patterns and outcome of 1,776 consecutive patients from the Besancon stroke registry. Cerebrovasc Dis 10 (2000) 261-271
6. Di Carlo A., Lamassa M., Baldereschi M., Pracucci G., Consoli D., Wolfe C.D., et al. Risk factors and outcome of subtypes of ischemic stroke. Data from a multicenter multinational hospital-based registry. The European Community Stroke Project. J Neurol Sci 244 (2006) 143-150
7. Cha J.K., Jeong M.H., Jang J.Y., Bae H.R., Lim Y.J., Kim J.S., et al. Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischemic stroke. A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke. Cerebrovasc Dis 16 (2003) 376-382
8. Marquardt L., Ruf A., Mansmann U., Winter R., Schuler M., Buggle F., et al. Course of platelet activation markers after ischemic stroke. Stroke 33 (2002) 2570-2574
9. McCabe D.J., Harrison P., Mackie I.J., Sidhu P.S., Purdy G., Lawrie A.S., et al. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 125 (2004) 777-787
10. Htun P., Fateh-Moghadam S., Tomandl B., Handschu R., Klinger K., Stellos K., et al. Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia. Stroke 37 (2006) 2283-2287
11. Goldstein L.B., Adams R., Alberts M.J., Appel L.J., Brass L.M., Bushnell C.D., et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113 (2006) e873-e923
12. Sacco R.L., Adams R., Albers G., Alberts M.J., Benavente O., Furie K., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37 (2006) 577-617
13. Sulter G., Steen C., and De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 30 (1999) 1538-1541
14. Schmitz G., Rothe G., Ruf A., Barlage S., Tschope D., Clemetson K.J., et al. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 79 (1998) 885-896
15. Henn V., Steinbach S., Buchner K., Presek P., and Kroczek R.A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98 (2001) 1047-1054
16. Nomura S., Shouzu A., Omoto S., Nishikawa M., and Fukuhara S. Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 121 (2000) 437-443
17. Gawaz M., Neumann F.J., Ott I., Schiessler A., and Schomig A. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation 93 (1996) 229-237
18. Ott I., Neumann F.J., Gawaz M., Schmitt M., and Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 94 (1996) 1239-1246
19. Michelson A.D., Barnard M.R., Krueger L.A., Valeri C.R., and Furman M.I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104 (2001) 1533-1537
20. Furman M.I., Barnard M.R., Krueger L.A., Fox M.L., Shilale E.A., Lessard D.M., et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 38 (2001) 1002-1006
21. Yilmaz G., Arumugam T.V., Stokes K.Y., and Granger D.N. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113 (2006) 2105-2112
22. Huang J., Upadhyay U.M., and Tamargo R.J. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66 (2006) 232-245
23. Buck B.H., Liebeskind D.S., Saver J.L., Bang O.Y., Yun S.W., Starkman S., et al. Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke 39 (2008) 355-360
24. Faraday N., Scharpf R.B., Dodd-o J.M., Martinez E.A., Rosenfeld B.A., and Dorman T. Leukocytes can enhance platelet-mediated aggregation and thromboxane release via interaction of P-selectin glycoprotein ligand 1 with P-selectin. Anesthesiology 94 (2001) 145-151
25. Emerich D.F., Dean III R.L., and Bartus R.T. The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?. Exp Neurol 173 (2002) 168-181
26. Warlow C.P. Epidemiology of stroke. Lancet 352 Suppl 3 (1998) SIII1-SIII4
27. Megherbi S.E., Milan C., Minier D., Couvreur G., Osseby G.V., Tilling K., et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke 34 (2003) 688-694
28. Yip H.K., Liou C.W., Chang H.W., Lan M.Y., Liu J.S., and Chen M.C. Link between platelet activity and outcomes after an ischemic stroke. Cerebrovasc Dis 20 (2005) 120-128
29. Grau A.J., Reiners S., Lichy C., Buggle F., and Ruf A. Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study. Stroke 34 (2003) 849-854
30. Yamazaki M., Uchiyama S., and Iwata M. Measurement of platelet fibrinogen binding and p-selectin expression by flow cytometry in patients with cerebral infarction. Thromb Res 104 (2001) 197-205
31. Zeller J.A., Tschoepe D., and Kessler C. Circulating platelets show increased activation in patients with acute cerebral ischemia. Thromb Haemost 81 (1999) 373-377
32. Yip H.K., Chen S.S., Liu J.S., Chang H.W., Kao Y.F., Lan M.Y., et al. Serial changes in platelet activation in patients after ischemic stroke: role of pharmacodynamic modulation. Stroke 35 (2004) 1683-1687
33. Nomura S., Shouzu A., Omoto S., Nishikawa M., Fukuhara S., and Iwasaka T. Losartan and simvastatin inhibit platelet activation in hypertensive patients. J Thromb Thrombolysis 18 (2004) 177-185
34. Knight C.J., Panesar M., Wilson D.J., Chronos N.A., Patel D., Fox K., et al. Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina. Circulation 95 (1997) 125-132